Association of Diphtheria-Tetanus–Acellular Pertussis Vaccine Timeliness and Number of Doses With Age-Specific Pertussis Risk in Infants and Young Children

IMPORTANCE: In most countries, the diphtheria-tetanus–acellular pertussis (DTaP) vaccine is administered as a 3-dose infant series followed by additional booster doses in the first 5 years of life. Short-term immunity from the DTaP vaccine can depend on the number, timing, and interval between doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Rane, Madhura S., Rohani, Pejman, Halloran, M. Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356064/
https://www.ncbi.nlm.nih.gov/pubmed/34374773
http://dx.doi.org/10.1001/jamanetworkopen.2021.19118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356064/
https://www.ncbi.nlm.nih.gov/pubmed/34374773
http://dx.doi.org/10.1001/jamanetworkopen.2021.19118

Ejemplares similares